Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-04

Clinical Trial Update: A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics, safety, and tolerability of oxcarbazepine when co-administered with padsevonil in participants with epilepsy; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)
  • Padsevonil (padsevonil)

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2020-06-04